UZH-Logo

GDF-15 contributes to proliferation and immune escape of malignant gliomas


Roth, P; Junker, M; Tritschler, I; Mittelbronn, M; Dombrowski, Y; Breit, S N; Tabatabai, G; Wick, W; Weller, M; Wischhusen, J (2010). GDF-15 contributes to proliferation and immune escape of malignant gliomas. Clinical Cancer Research, 16(5):3851-3859.

Abstract

PURPOSE: Growth and differentiation factor (GDF)-15 is a member of the transforming growth factor (TGF)-beta family. GDF-15 is necessary for the maintenance of pregnancy but has also been linked to other physiological and pathological conditions. EXPERIMENTAL DESIGN: The expression of GDF-15 in glioma cell lines was assessed by qRT-PCR and immunoblot. GDF-15 levels in situ and in peripheral blood of glioma patients were examined by immunohistochemistry and ELISA, respectively. Effects of shRNA-mediated GDF-15 inhibition on proliferation and immunogenicity of SMA-560 glioma cells were investigated by [methyl-3H]thymidine incorporation and immune-mediated target cell lysis. The impact of GDF-15 on glioma growth in vivo was assessed in syngeneic mice.RESULTS: GDF-15 is expressed by gliomas of different WHO grades as assessed by immunohistochemistry. The high expression of GDF-15 in tumor tissue translates into elevated GDF-15 serum levels in glioblastoma patients compared to healthy controls. GDF-15 mRNA and protein are also detectable in human and mouse glioma cells in vitro. Silencing of GDF-15 by RNA interference reduces the proliferation of malignant glioma cells. Immunologically, the depletion of glioma-derived GDF-15 enhances the susceptibility of mouse glioma cells towards syngeneic NK cells and splenocytes. This results into a reduced in vivo tumorigenicity and increased T cell infiltration of GDF-15-deficient glioma cells in syngeneic mice. CONCLUSIONS: While previous studies focussing on ectopic overexpression of GDF-15 have proposed unclear or anti-tumorigenic effects of GDF-15 in glioma cells, we here show that GDF-15 at endogenous levels contributes to proliferation and immune escape of malignant gliomas in an immunocompetent host.

PURPOSE: Growth and differentiation factor (GDF)-15 is a member of the transforming growth factor (TGF)-beta family. GDF-15 is necessary for the maintenance of pregnancy but has also been linked to other physiological and pathological conditions. EXPERIMENTAL DESIGN: The expression of GDF-15 in glioma cell lines was assessed by qRT-PCR and immunoblot. GDF-15 levels in situ and in peripheral blood of glioma patients were examined by immunohistochemistry and ELISA, respectively. Effects of shRNA-mediated GDF-15 inhibition on proliferation and immunogenicity of SMA-560 glioma cells were investigated by [methyl-3H]thymidine incorporation and immune-mediated target cell lysis. The impact of GDF-15 on glioma growth in vivo was assessed in syngeneic mice.RESULTS: GDF-15 is expressed by gliomas of different WHO grades as assessed by immunohistochemistry. The high expression of GDF-15 in tumor tissue translates into elevated GDF-15 serum levels in glioblastoma patients compared to healthy controls. GDF-15 mRNA and protein are also detectable in human and mouse glioma cells in vitro. Silencing of GDF-15 by RNA interference reduces the proliferation of malignant glioma cells. Immunologically, the depletion of glioma-derived GDF-15 enhances the susceptibility of mouse glioma cells towards syngeneic NK cells and splenocytes. This results into a reduced in vivo tumorigenicity and increased T cell infiltration of GDF-15-deficient glioma cells in syngeneic mice. CONCLUSIONS: While previous studies focussing on ectopic overexpression of GDF-15 have proposed unclear or anti-tumorigenic effects of GDF-15 in glioma cells, we here show that GDF-15 at endogenous levels contributes to proliferation and immune escape of malignant gliomas in an immunocompetent host.

Citations

34 citations in Web of Science®
36 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

32 downloads since deposited on 15 Jul 2010
18 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:July 2010
Deposited On:15 Jul 2010 14:38
Last Modified:05 Apr 2016 14:11
Publisher:American Association for Cancer Research
ISSN:1078-0432
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:10.1158/1078-0432.CCR-10-0705
PubMed ID:20534737
Permanent URL: http://doi.org/10.5167/uzh-34877

Download

[img]Content: Published Version
Filetype: PDF - Registered users only
Size: 539kB
View at publisher

[img]
Preview
Content: Accepted Version
Filetype: PDF
Size: 516kB

TrendTerms

TrendTerms displays relevant terms of the abstract of this publication and related documents on a map. The terms and their relations were extracted from ZORA using word statistics. Their timelines are taken from ZORA as well. The bubble size of a term is proportional to the number of documents where the term occurs. Red, orange, yellow and green colors are used for terms that occur in the current document; red indicates high interlinkedness of a term with other terms, orange, yellow and green decreasing interlinkedness. Blue is used for terms that have a relation with the terms in this document, but occur in other documents.
You can navigate and zoom the map. Mouse-hovering a term displays its timeline, clicking it yields the associated documents.

Author Collaborations